Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Danaher Corporation is a global science and technology innovator specializing in medical diagnostics, life sciences, and environmental solutions. Its competitive position is strengthened by a diverse portfolio of high-margin products, including the Leica Biosystems and Beckman Coulter brands, which cater to healthcare providers across North America and Europe.
Danaher generates revenue through the sale of analytical instruments, reagents, consumables, and software solutions. Its pricing power is supported by a strong brand reputation and a focus on innovation, allowing it to maintain high gross margins.
Regulatory approvals for new diagnostic tests
Demand fluctuations in healthcare spending
Acquisitions that expand product offerings or market reach
Currency fluctuations impacting international sales
Technological disruption from emerging diagnostic technologies
Regulatory changes affecting product approvals and market access
Increased competition from both established players and startups in the diagnostics space
Price pressure from generic diagnostic products
Moderate financial risk due to potential for increased leverage from acquisitions
Liquidity risks if cash flow generation does not meet expectations
moderate - Danaher's performance is closely linked to healthcare spending, which can be cyclical but is generally resilient during economic downturns.
Higher interest rates could increase financing costs for acquisitions and R&D investments, potentially impacting growth and valuation multiples.
minimal - Danaher maintains a manageable debt-to-equity ratio of 0.51, indicating low reliance on external financing.
growth - due to its focus on innovation and expansion in high-demand healthcare sectors.
moderate - historical beta suggests less volatility compared to the broader market.